StemCells (STEM) Posts Q1 Results and Data Is Coming, Maxim Group Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
StemCells (STEM) Bullish Stance Reiterated at Maxim Group on Positive Spine Paralysis Data
May 19, 2014 11:57 AM EDTMaxim Group analyst Jason Kolbert reiterated his Buy rating and $2.50 price target on StemCells (NASDAQ: STEM) following positive data on spine paralysis.
Kolbert notes,... More
Stemcells (STEM) Posts Mixed Q1 Results
May 14, 2014 4:02 PM EDTStemcells (NASDAQ: STEM) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $339 thousand versus the consensus estimate of $240 thousand.
For earnings history and earnings-related data on Stemcells (STEM) click here.
... More